Scarica l'app Stockscreener
343.32
1.46%
4.94
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SYK Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$338.38
Aprire:
$342.02
Volume 24 ore:
2.46M
Relative Volume:
1.19
Capitalizzazione di mercato:
$131.49B
Reddito:
$25.12B
Utile/perdita netta:
$3.25B
Rapporto P/E:
40.88
EPS:
8.3984
Flusso di cassa netto:
$4.28B
1 W Prestazione:
+1.23%
1M Prestazione:
-1.66%
6M Prestazione:
-8.31%
1 anno Prestazione:
-0.92%
Intervallo 1D:
$341.06
$347.52
Intervallo di 1 settimana:
$336.52
$352.80
Portata 52W:
$319.32
$404.14
Stryker Corp Stock (SYK) Company Profile
Nome
Stryker Corp
Settore
Industria
Telefono
(269) 385-2600
Indirizzo
1941 STRYKER WAY, PORTAGE, MI
Compare SYK vs ABT, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
343.32 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
ABT
Abbott Laboratories
|
96.81 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
MDT
Medtronic Plc
|
86.19 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.23 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.99 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-13 | Iniziato | Leerink Partners | Outperform |
| 2026-02-20 | Iniziato | William Blair | Outperform |
| 2026-01-27 | Ripresa | TD Cowen | Hold |
| 2026-01-06 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2025-12-19 | Aggiornamento | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-09-18 | Iniziato | Rothschild & Co Redburn | Neutral |
| 2025-02-26 | Ripresa | Citigroup | Buy |
| 2024-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-10 | Iniziato | Wolfe Research | Outperform |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-22 | Aggiornamento | Needham | Hold → Buy |
| 2024-01-31 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2023-10-20 | Iniziato | ROTH MKM | Buy |
| 2023-09-05 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-01-25 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2023-01-09 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-11-01 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-28 | Aggiornamento | Edward Jones | Hold → Buy |
| 2022-07-21 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-07-11 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-04-13 | Iniziato | Truist | Hold |
| 2022-03-16 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2022-03-15 | Ripresa | Evercore ISI | Outperform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-12-07 | Iniziato | Loop Capital | Buy |
| 2021-09-14 | Ripresa | Raymond James | Mkt Perform |
| 2021-07-28 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2021-06-01 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2021-05-25 | Iniziato | Barclays | Underweight |
| 2020-10-06 | Iniziato | Northland Capital | Market Perform |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-04-13 | Downgrade | Barclays | Equal Weight → Underweight |
| 2020-04-01 | Downgrade | Goldman | Buy → Sell |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-08 | Iniziato | SunTrust | Hold |
| 2020-01-07 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2019-12-30 | Reiterato | BTIG Research | Buy |
| 2019-11-05 | Downgrade | Barclays | Overweight → Equal Weight |
| 2019-10-30 | Reiterato | BofA/Merrill | Buy |
| 2019-07-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-01-30 | Reiterato | Canaccord Genuity | Buy |
| 2019-01-03 | Iniziato | Deutsche Bank | Buy |
| 2019-01-02 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-08-16 | Iniziato | BTIG Research | Buy |
| 2018-06-27 | Iniziato | Bernstein | Mkt Perform |
| 2018-04-27 | Reiterato | Stifel | Buy |
Mostra tutto
Stryker Corp Borsa (SYK) Ultime notizie
Stryker Corporation (NYSE:SYK) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Stryker (NYSE:SYK) Downgraded to "Hold" Rating by Wall Street Zen - MarketBeat
Stryker Corp. stock outperforms competitors on strong trading day - MarketWatch
Farther Finance Advisors LLC Boosts Stake in Stryker Corporation $SYK - MarketBeat
Stryker Corporation $SYK Shares Sold by Campbell Newman Asset Management Inc. - MarketBeat
Cystoscopy and Ureteroscopy Market 2026 | Stryker Corp, Rudra Surgicals, Teleflex Inc, Coloplast Corp etc. - openPR.com
Stryker Hack Affects First Quarter Results - BankInfoSecurity
Ambulatory Surgical Equipment Market to Reach USD 14.58 Billion, Rising at 7.85% by 2035 - GlobeNewswire Inc.
Stryker leads West Michigan public companies with $25.1B in revenue - Crain's Grand Rapids
Berger Montague PC Investigates Stryker Corporation's Board of Directors for Breach of Fiduciary Duty (NYSE: SYK) - marketscreener.com
KBC Group NV Increases Position in Stryker Corporation $SYK - MarketBeat
Lbp Am Sa Has $84.59 Million Stake in Stryker Corporation $SYK - MarketBeat
Annex Advisory Services LLC Sells 15,163 Shares of Stryker Corporation $SYK - MarketBeat
General Dynamics wins $44.4M contract modification for Stryker upgrades - Investing.com
US FDA Stryker updates use instructions for patient-fitted tmj implants - marketscreener.com
Stryker Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Stryker Corp stock (US8636671013): Why its medtech leadership position matters more now for investor - AD HOC NEWS
Stryker (NYSE:SYK) Price Target Lowered to $380.00 at Truist Financial - MarketBeat
Stryker Cyberattack Has Impacted First Quarter Earnings - The HIPAA Journal
Citi Maintains Stryker Corp(SYK.US) With Buy Rating, Maintains Target Price $385 - 富途牛牛
Stryker Corp. stock (US8636671013): Is its medtech moat strong enough to unlock new upside? - AD HOC NEWS
Stryker Corp stock (US8636671013): Why its medtech leadership matters more now for long-term investo - AD HOC NEWS
Stryker Corp. stock (US8636671013): Is medtech innovation strong enough to unlock new upside? - AD HOC NEWS
Ronda Stryker (SYK) updates 15.2M-share beneficial stake and recent trades - Stock Titan
Stryker's Q1 Results to See Material Impact From March Cybersecurity Incident, RBC Says - marketscreener.com
Stryker to Acquire AVS, Adding IVL Capabilities to Vascular Portfolio - Zacks Investment Research
A Quick Look at Today's Ratings for Stryker Corp(SYK.US), With a Forecast Between $397 to $435 - 富途牛牛
Sleeping Giant acquires Walker manufacturer, taps Stryker veteran as CEO - Crain's Grand Rapids
SYK Initiated by Leerink Partners -- Rating Set to Outperform - GuruFocus
Stryker (SYK) to Acquire Amplitude Vascular Systems - GuruFocus
Stryker agrees to buy Amplitude Vascular Systems for IVL tech - BioWorld News
Stryker agrees to acquire IVL developer Amplitude Vascular Systems - Yahoo Finance
Stryker (SYK) Expands Vascular Portfolio with Amplitude Vascular Acquisition - GuruFocus
Stryker to Acquire Amplitude Vascular Systems - Medical Product Outsourcing
Stryker (NYSE:SYK) Coverage Initiated by Analysts at Leerink Partners - MarketBeat
Leerink Partners Initiates Stryker Corp(SYK.US) With Buy Rating, Announces Target Price $410 - 富途牛牛
Truist Financial Maintains Stryker Corp(SYK.US) With Hold Rating - 富途牛牛
Stryker to acquire vascular device maker Amplitude Vascular By Investing.com - Investing.com Canada
Stryker to acquire vascular device maker Amplitude Vascular - Investing.com
Stryker targets next-gen artery treatment with Amplitude deal - Stock Titan
‘Not a surprise’ Stryker didn’t renew local office space, experts say - Daily Memphian
SYK SEC FilingsStryker Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Stryker is fully operational after cyberattack - MedTech Dive
Stryker expects cyberattack to impact Q1 results - BioWorld News
Stryker (SYK) Confident in 2026 Guidance Despite Cybersecurity I - GuruFocus
Stryker confident of 2026 outlook despite Q1 impact from cyberattack - Seeking Alpha
Truist reiterates Hold on Stryker stock after cyberattack update - Investing.com
Piper Sandler Maintains Stryker Corp(SYK.US) With Buy Rating, Maintains Target Price $420 - Moomoo
Stryker Corporation Discloses Material Cybersecurity Incident in March 2026 8-K/A Filing - Minichart
[8-K/A] STRYKER CORP Amends Material Event Report - Stock Titan
Goldman Sachs Lowers Stryker (SYK) Price Target Amid Neutral Rat - GuruFocus
Stryker Corp Azioni (SYK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):